Welcome to our dedicated page for AlphaTON Capital news (Ticker: ATON), a resource for investors and traders seeking the latest updates and insights on AlphaTON Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AlphaTON Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AlphaTON Capital's position in the market.
AlphaTON Capital Corp (formerly Portage Biotech) announced a strategic transformation to become a specialized digital asset treasury company focused on the TON blockchain and Telegram ecosystem. The company appointed Brittany Kaiser as CEO and will trade under the new ticker "ATON" starting September 4, 2025.
The company secured $38.2 million through private placement and a $35 million loan facility from BitGo Prime to acquire approximately $100 million worth of TON tokens. The strategy includes building a TON treasury, implementing yield generation through validation and staking, and developing ecosystem projects within Telegram's billion-user platform.
Strategic partnerships include notable firms like BitGo, Animoca Brands, and SkyBridge, with advisors including Anthony Scaramucci and Michael Terpin.
FAQ
What is the current stock price of AlphaTON Capital (ATON)?
